Jim Goldschmidt

Jim Goldschmidt has a diverse work experience spanning over three decades in the pharmaceutical industry. Jim most recently served as the Senior Vice President at CASI Pharmaceuticals, Inc. starting in April 2016. Prior to that, they held the position of Chief Operating Officer at Macrophage Therapeutics, Inc. from January 2015 to March 2016. In 2014, they worked as the Vice President of Business Development at ImmuneXcite, Inc. Jim's extensive experience also includes senior roles at TetraLogic Pharmaceuticals, Johnson & Johnson, Wyeth Pharmaceuticals, and SmithKline Beecham, where they held various leadership positions in commercial development, strategic marketing, product development, and business planning.

Jim Goldschmidt obtained a Bachelor of Science (BS) degree from Villanova University. Jim then pursued a Master's degree in Biomedical Engineering from Drexel University. Following that, they attended Temple University - Lewis Katz School of Medicine to earn a Doctor of Philosophy (PhD) degree in Pharmacology.